Skip to main content

Advertisement

Advertisement

World

Poland starts J&J COVID-19 jabs, says benefits outweigh risks

Poland starts J&J COVID-19 jabs, says benefits outweigh risks

FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020. REUTERS/Dado Ruvic

WARSAW: Poland started administering Johnson & Johnson COVID-19 shots on Thursday (Apr 15) as benefits from the vaccine outweigh potential risks, government and drug office representatives said.

US federal health agencies on Tuesday recommended pausing use of Johnson & Johnson's vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic.

"In the case of Johnson & Johnson today is the first day it has been used. We have not received signals that there are problems, or that patient are refusing (to take it)," Michal Dworczyk, a government official overseeing the country's vaccine programme told a press conference.

The head of the Office for Registration of Medicinal Products told the conference that benefits from the J&J vaccine outweigh potential risks.

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Advertisement

Also worth reading

Advertisement